BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bassyouni IH, Fawzi S, Gheita TA, Bassyouni RH, Nasr AS, El Bakry SA, Afifi N. Clinical Association of a Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) in Patients with Systemic Lupus Erythematosus. Immunol Invest 2017;46:38-47. [PMID: 27648678 DOI: 10.1080/08820139.2016.1211140] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Qin L, Mohan C. Non-invasive biomarkers for systemic lupus erythematosus: A lookback at 2016. Int J Rheum Dis 2016;19:1209-15. [PMID: 28371439 DOI: 10.1111/1756-185X.13075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ugurlu S, Egeli BH. In Familial Mediterranean Fever, soluble TREM-1 plasma level is higher in case of amyloidosis. Innate Immun 2020;26:231. [PMID: 32122207 DOI: 10.1177/1753425920908645] [Reference Citation Analysis]
3 Wang P, Mao YM, Liu LN, Zhao CN, Li XM, Pan HF. Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus. Immunol Invest 2020;49:69-80. [PMID: 31412748 DOI: 10.1080/08820139.2019.1649280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Edel Y, Kliminski V, Pokroy-Shapira E, Oren S, Dortort Lazar A, Pri-Paz Basson Y, Egbaria M, Molad Y. Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome. Arthritis Res Ther 2019;21:10. [PMID: 30616644 DOI: 10.1186/s13075-018-1779-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lu L, Liu X, Fu J, Liang J, Hou Y, Dou H. sTREM-1 promotes the phagocytic function of microglia to induce hippocampus damage via the PI3K-AKT signaling pathway. Sci Rep 2022;12:7047. [PMID: 35487953 DOI: 10.1038/s41598-022-10973-8] [Reference Citation Analysis]
6 Vázquez-Otero I, Rodríguez-Navedo Y, Vilá-Rivera K, Nieves-Plaza M, Morales-Ortiz J, Washington AV, Vilá LM. Association of soluble TREM-like transcript-1 with clinical features and patient reported outcomes in systemic lupus erythematosus. Eur J Rheumatol 2018;5:244-8. [PMID: 30308137 DOI: 10.5152/eurjrheum.2018.18074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Gao S, Yi Y, Xia G, Yu C, Ye C, Tu F, Shen L, Wang W, Hua C. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases. Autoimmun Rev 2019;18:25-35. [PMID: 30408584 DOI: 10.1016/j.autrev.2018.07.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
8 Ugurlu S, Egeli BH, Bolayirli IM, Ozdogan H. Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-Amyloidosis. Immunol Invest 2021;50:273-81. [PMID: 32321335 DOI: 10.1080/08820139.2020.1751195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Wang Z, Chi H, Sun Y, Teng J, Feng T, Liu H, Cheng X, Ye J, Shi H, Hu Q, Jia J, Liu T, Wan L, Zhou Z, Qiao X, Yang C, Su Y. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course. Rheumatology (Oxford) 2020;59:3293-302. [PMID: 32276274 DOI: 10.1093/rheumatology/keaa135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Ates D, Doner HC, Kurban S, Koksal H. The Effect of Soluble TREM-1 in Idiopathic Granulomatous Mastitis. Immunol Invest 2021;:1-12. [PMID: 33522329 DOI: 10.1080/08820139.2021.1879846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]